220 likes | 620 Views
MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII INFECTION IN RESPIRATORY INTENSIVE CARE UNIT. Pervin Korkmaz Ekren 1 , M. Sezai Tasbakan 1 , Burcu Basarık 1 , Husnu Pullukcu 2 , Sohret Aydemir 3 , Alev Gurgun 1 , Ozen Kacmaz Basoglu 1 , Feza Bacakoglu 1.
E N D
MULTIDRUG-RESISTANT ACINETOBACTER BAUMANNII INFECTION IN RESPIRATORY INTENSIVE CARE UNIT Pervin Korkmaz Ekren1, M. Sezai Tasbakan1, Burcu Basarık1, Husnu Pullukcu2, Sohret Aydemir3, Alev Gurgun1, Ozen Kacmaz Basoglu1, Feza Bacakoglu1 Ege University School of MedicineDepartments of 1 Chest Diseases, 2Infection Disease and Clinic Microbiology, 3Microbiology and Clinic Microbiology
Nosocomial Infections (1) • Multidrug-resistant (MDR) Gram-negative bacilli!!! • Acinetobacter baumannii : - Developing of antimicrobial resistance is extremely rapid - This resistance is multiple Serious therapeutic problems
Nosocomial Infections (2) Acinetobacter baumannii: - Bacteremia - Urinary tract infection - Secondary meningitis
Nosocomial Infections (2) Acinetobacter baumannii: - Bacteremia - Urinary tract infection - Secondary meningitis - Nosocomial pneumonia In intensive care units (ICU) Role in ventilator-associated pneumonia (VAP)↑
Method • Ege University, Department of Chest Diseases • Respiratory ICU • December 2005 – December 2007 • 218 patients 58 patients (26.6% ) MDR A.baumanni Infection (-) MDR A.baumanni Infection (+) • 37 patients included in this study
Table 1. Severity of diseases and characteristics of patients with MDR A.baumannii infections Results-1 Abbreviations: CAP= Community-acquired pneumoniae; NP= Nosocomial pneumoniae; COPD= Chronic obstructive lung disease; PIP= Pneumoniae at immunocompromised patients; TB= Tuberculosis; OSAS=Obstructive sleep apne syndrome; ARDS= “Acute respiratory distress syndrome”; APACHE II= “Acute Physiology and Chronic Health Evaluation”. *Causes of immunsuppresion: Haematological malignancy (4 cases), collagen vascular disease (2 cases), renal transplantation (1 case), renal failure (1 case)
Results-2 • 31 patients ( 83.7 % ) Invasive mechanical ventilation • Patients with MDR A.baumannii infections; 24.3 % 59.5 % Pneumoniae 100 % of them
Results-3 Figure 1. Rates of samples that MDR A.baumannii isolated (%) Abbreviations: ETA= Endotracheal aspiration; FOB= Fiberoptic bronchoscopy.
Results-4 Table 2. Clinical characteristics of patients at the time of the MDR A.baumannii infections Abbreviations: ICU=İntensive care unit; VAP= ventilator-associated pneumonia; CRP= C-reaktive protein; SIRS= Systemic inflamatory response syndrome; ARDS= “Acute respiratory distress syndrome”. *mean±SD
Results-5 Table 3. Risk factors at patients with MDR A.baumannii infections
Results-6 Figure 2. Antibiotics that used at the time of MDR A.baumannii infections (%)
Results-7 Drug-resistance to all antibiotics was observed in 62.2% of patients (%) Figure 3. Rates of antibiotic resistances for A.baumannii that isolated
Results-8 Figure 4. Use of antibiotics for MDR A.baumannii infections Duration of antimicrobial therapy: 13.3±6.7 days (%)
Results-9 Table 4. Characteristics, risk factors and prognosis of patients with/without MDR A.baumannii infections Abbreviatios: MDR= Multidrug resistant; ICU=Intensive care unit. * mean±SD
Discussion (1) • Infections with A.baumannii in ICUs • Antibiotic resistance • VİP due toMDR A.baumannii; • antimicrobial therapy
Discussion (2) • Pneumoniae withMDR A.baumannii • - prognosis is similar • - durations of ICU and hospital stays are • increasing
Conclusions • In the our respiratory ICU • infections with MDR A.baumannii :% 26.6 % 59.5 VİP % 24.3 bacteraemia Drug-resistance to all antibiotics was Observedin 62.2% of patients